ClinConnect ClinConnect Logo
Search / Trial NCT03320824

New Dermal Filler for Lip Augmentation

Launched by GALDERMA R&D · Oct 20, 2017

Trial Information

Current as of July 24, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects willing to comply with the requirements of the study and providing a signed written informed consent.
  • Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
  • Seeking augmentation therapy for the lips
  • Exclusion Criteria:
  • Allergy of hypersensitivity to any injectable hyaluronic acid gel or to gram positive bacterial proteins.
  • Allergy or hypersensitivity to lidocaine or other amide-type anesthetics, or topical anesthetics or nerve blocking agents.

About Galderma R&D

Galderma R&D is a global leader in dermatological innovation, dedicated to advancing skin health through rigorous research and development. With a strong commitment to scientific excellence, Galderma focuses on creating effective and safe treatments for a variety of skin conditions, including acne, rosacea, and psoriasis. The organization collaborates with healthcare professionals and researchers worldwide to bring cutting-edge solutions to market, ensuring that patients receive the highest quality care. Through its extensive clinical trials and commitment to regulatory compliance, Galderma R&D strives to enhance the understanding of dermatological diseases and improve patient outcomes.

Locations

Miami, Florida, United States

Chestnut Hill, Massachusetts, United States

Alpharetta, Georgia, United States

New York, New York, United States

Solana Beach, California, United States

Birmingham, Michigan, United States

San Diego, California, United States

Nashville, Tennessee, United States

Encino, California, United States

Coral Gables, Florida, United States

West Palm Beach, Florida, United States

Hunt Valley, Maryland, United States

Chapel Hill, North Carolina, United States

Dallas, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials